Filing Details

Accession Number:
0000899243-21-048904
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-17 20:43:19
Reporting Period:
2021-12-15
Accepted Time:
2021-12-17 20:43:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1832415 Better Therapeutics Inc. BTTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1547557 J Kevin Appelbaum C/O Better Therapeutics, Inc.
548 Market Street, #49404
San Francisco CA 94104
Chief Executive Officer Yes Yes Yes No
1890904 Kevin Appelbaum, Or His Successor(S), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended C/O Better Therapeutics, Inc.
548 Market Street, #49404
San Francisco CA 94104
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-15 750 $4.71 2,750 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,406,719 Indirect By Trust
Footnotes
  1. These shares are owned directly by Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated May 16, 2020, as amended (the "Trust"), and indirectly by Mr. Appelbaum as trustee of the Trust. Mr. Appelbaum is an officer, director and ten percent owner of Issuer.